HAVCR2 and non-Hodgkin lymphoma: One of the strong pieces of evidence implicating TIM-3 as an immune checkpoint receptor came from independent studies of germline loss-of-function mutations (Tyr82Cys or Ile97Met) of HAVCR2 (encoding TIM-3) in non-Hodgkin lymphoma patients.